Organic Coatings (531157)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹16.97 |
| Market Cap | ₹13.02 Cr |
| P/E Ratio | 0 |
| ROCE | -8.15% |
| ROE | -423.9% |
| Dividend Yield | 0% |
| Profit Growth | -7.87% |
| Debt/Equity | — |
| Sales Growth | 73.16% |
| 52-Week Range | ₹14.25 — ₹30.43 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹0.87 |
Strengths
- Revenue growth is strong at 73.16%, showing some business momentum.
- Latest quarter sales of ₹6 Cr indicate an expanding operating base, albeit from a low level.
- A positive book value of ₹0.87, though small, provides a minimal asset floor.
- Trading near the bottom of its 52-week range may attract speculative interest.
Concerns
- No earnings: P/E is 0.00 and latest quarter shows a net loss of ₹1 Cr.
- Extremely poor returns: ROE is -423.90% and ROCE is -8.15%.
- Valuation is expensive at P/B of 19.51 versus book value of ₹0.87.
- Weak fundamentals: Piotroski score of 3/9, zero dividend, and promoter holding not disclosed.
AI Analysis
Let me be blunt: this is not the kind of business I would normally spend a rupee on. Organic Coatings has a market cap of just ₹13 Cr, and yet the market is asking me to pay 19.51 times book value for a company whose book value is only ₹0.87 per share. That is a rich price for a business earning nothing. With a P/E of 0.00 and a latest quarter showing ₹6 Cr in sales but a net loss of ₹1 Cr, there is no earnings stream to justify the valuation. The 73.16% sales growth sounds exciting, but a small specialty chemicals firm growing from a tiny base while losing money is not proof of a moat. It is proof of hope, and hope is not an investment strategy. The Piotroski score of 3 out of 9 tells me the financial health is weak, and the ROE of -423.90% and ROCE of -8.15% confirm capital is being destroyed, not productively deployed. There is no dividend to compensate me while I wait, and with promoter holding not disclosed, I cannot even gauge whether those running the show have skin in the game. This could be a turnaround story if the sales growth eventually flows into profits, but a turnaround is only worth investing in before the market prices it as one. At ₹16.97, near the lower end of its 52-week range of ₹13.10 to ₹30.43, the stock may look cheap on a price chart, but it is not cheap on any fundamental measure I respect. In Graham's words, price is what you pay, value is what you get. Here, I struggle to find the value.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer